OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.770
0.00 (0.00%)
Nov 5, 2026, 10:56 AM EST - Market open

OPKO Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-148.06-225.68-53.22-188.86-328.41-30.14
Depreciation & Amortization
89.7191.6398.18105.3108.6678.72
Other Amortization
0.555.231.971.221.160.79
Loss (Gain) From Sale of Assets
-17.31-104.82-184.891.32-19.01-33.92
Asset Writedown & Restructuring Costs
-1.01----
Loss (Gain) From Sale of Investments
-3.580.62-114.4317.65153.843.97
Loss (Gain) on Equity Investments
5.020.030.020.110.380.63
Stock-Based Compensation
9.8910.7111.0511.4118.5113.63
Other Operating Activities
-51.5383.9125.661.86-72.9725.16
Change in Accounts Receivable
14.0530.21-0.223.41128.65.23
Change in Inventory
2.25-4.124.2215.213.6630.68
Change in Accounts Payable
-9.08-14.22-20.662.83-9.39-10.85
Change in Unearned Revenue
------15.91
Change in Other Net Operating Assets
-16.95-53.0648.840.36-90.22-29.64
Operating Cash Flow
-125.05-178.54-183.49-28.2-95.1938.34
Operating Cash Flow Growth
------2.89%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-10.29-12.28-25.01-16.28-24.58-32.16
Sale of Property, Plant & Equipment
38.45198.06210.622.711.9566.03
Cash Acquisitions
-----1.76-4
Sale (Purchase) of Intangibles
-0.5-----
Investment in Securities
-4.6744.52166.6-4.64115.426.08
Investing Cash Flow
22.99230.3352.21-18.291.0435.95

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-33.03939.43671.681,0601,685
Long-Term Debt Repaid
--103.79-651.45-682.71-1,036-1,696
Net Debt Issued (Repaid)
123.14-70.76287.98-11.0323.75-11.24
Issuance of Common Stock
-----1.08
Repurchase of Common Stock
-41.93-47.04-90.22---
Other Financing Activities
-3.27-0.26-13.59-0.27-0.77-0.19
Financing Cash Flow
77.95-118.06184.17-11.322.97-10.35

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.543.43-3.160.39-0.34-1.44
Net Cash Flow
-25.66-62.87349.73-57.3118.4862.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-135.34-190.82-208.5-44.47-119.776.18
Free Cash Flow Growth
-----6.68%
Free Cash Flow Margin
-20.69%-31.44%-29.24%-5.15%-11.93%0.35%
Free Cash Flow Per Share
-0.18-0.25-0.30-0.06-0.170.01
Levered Free Cash Flow
-257.2-131.25-128.816.65250.37-235.06
Unlevered Free Cash Flow
-228.27-68.7-101.1123.87256.75-224.05

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
37.9437.9420.888.147.428.52
Cash Income Tax Paid
24.4624.4610.013.718.045.97
Change in Working Capital
-9.74-41.1832.1821.842.65-20.48
SEC Filings: 10-K · 10-Q